- Trials with a EudraCT protocol (23)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
23 result(s) found for: Erysipelas.
Displaying page 1 of 2.
EudraCT Number: 2008-006794-32 | Sponsor Protocol Number: P071207 | Start Date*: 2009-09-11 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Etude Randomisée, de non Infériorité comparant Amoxicilline en traitement Court per os à un des traitements usuels (Amoxicilline IV relais per os) de l'érysipèle. = Short course of Amoxicilline for... | |||||||||||||
Medical condition: patient présentant un érysipèle primaire d'une jambe. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006151-42 | Sponsor Protocol Number: 0 | Start Date*: 2009-12-17 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Beaumont Hospital | |||||||||||||||||||||||||||||||||||||||||||
Full Title: A comparison of oral flucloxacillin alone with combined oral phenoxymethylpenicillin and flucloxacillin for the treatment of uncomplicated skin and soft tissue infections | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Infection of the skin and subcutaneous tissues (cellulitis) | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: IE (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002249-53 | Sponsor Protocol Number: P150924 | Start Date*: 2023-02-16 | |||||||||||
Sponsor Name:Assistance Publique - Hôpitaux de Paris (AP-HP) | |||||||||||||
Full Title: Comparing short to standard amoxicillin course for eRysipElas: a non-inferiority randomized controlled trial | |||||||||||||
Medical condition: Adults diagnosed with lower limbs erysipelas/ cellulitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002106-31 | Sponsor Protocol Number: 44512 | Start Date*: 2014-04-01 |
Sponsor Name:Academic Medical Center | ||
Full Title: The DANCE study: Duration of ANtibiotic therapy for CEllulitis | ||
Medical condition: Cellulitis (Cellulitis is a common acute, spreading pyogenic inflammation of the skin (dermis) and subcutaneous tissue, usually complicating a wound, ulcer or dermatosis) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-003812-22 | Sponsor Protocol Number: P903-23 | Start Date*: 2011-10-31 | |||||||||||
Sponsor Name:Cerexa, Inc. (subsidary of Forest Laboratories) | |||||||||||||
Full Title: A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Ceftaroline Versus Comparator in Pediatric Subjects With... | |||||||||||||
Medical condition: Acute Bacterial Skin and Skin Structure Infections | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA LT (Completed) LV (Completed) ES (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000381-36 | Sponsor Protocol Number: 26083 | Start Date*: 2006-04-26 |
Sponsor Name:University of Nottingham | ||
Full Title: Randomised controlled trials to investigate whether prophylactic antibiotics can prevent further episodes of cellulitis (erysipelas) of the leg (PATCH I & PATCH II) | ||
Medical condition: Cellulitis of the leg | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-003556-20 | Sponsor Protocol Number: RH4131-03 | Start Date*: 2014-02-19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Dept. of Intensive Care 4131, Copenhagen University Hospital, Rigshospitalet | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Necrotizing Soft Tissue Infections | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-002306-12 | Sponsor Protocol Number: S60382 | Start Date*: 2017-09-15 | |||||||||||
Sponsor Name: | |||||||||||||
Full Title: Determining the role of pre-existing factors, early diagnostic options and early treatment in the development of breast cancer related lymphedema. | |||||||||||||
Medical condition: breast cancer patients lymphedema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001297-63 | Sponsor Protocol Number: MLORI201 | Start Date*: 2023-04-13 |
Sponsor Name:Melinta Therapeutics, LLC | ||
Full Title: A Multicenter, Open-Label, Evaluator-Blinded, Randomized Study to Evaluate the Safety and Tolerability of Single-Dose IV Oritavancin Versus Standard of Care for the Treatment of Pediatric Subjects... | ||
Medical condition: Acute Bacterial Skin and Skin Structure Infections | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: BG (Trial now transitioned) LT (Trial now transitioned) LV (Trial now transitioned) PL (Trial now transitioned) ES (Ongoing) PT (Trial now transitioned) RO (Trial now transitioned) GR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022168-11 | Sponsor Protocol Number: TR-701-112 | Start Date*: 2011-03-08 | |||||||||||
Sponsor Name:Trius Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of 6-Day Oral TR-701 Free Acid and 10-Day Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin... | |||||||||||||
Medical condition: Acute Bacterial Skin and Skin Structure Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) LV (Completed) HU (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002860-26 | Sponsor Protocol Number: TR701-113 | Start Date*: 2011-12-21 | |||||||||||
Sponsor Name:Trius Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous to Oral 6-Day TR-701 Free Acid and Intravenous to Oral 10-Day Linezolid for the Treatment of... | |||||||||||||
Medical condition: Acute Bacterial Skin and Skin Structure Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004505-13 | Sponsor Protocol Number: TOFFIFE | Start Date*: 2017-11-27 | |||||||||||
Sponsor Name:University Hospital Tuebingen | |||||||||||||
Full Title: Tocilizumab for the Treatment of Familial Mediterranean Fever – A randomized, doubleblind, phase II proof of concept study-TOFFIFE | |||||||||||||
Medical condition: Adult patients with Familial Mediterranean Fever, who have active disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001840-83 | Sponsor Protocol Number: SAGA | Start Date*: 2022-04-26 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: Short-course aminoglycosides as adjunctive treatment in adults with sepsis | ||
Medical condition: Patients admitted with sepsis of unknown origin, suspected urinary origin or suspected abdominal origin | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001767-71 | Sponsor Protocol Number: RX-3341-302 | Start Date*: 2013-06-20 | |||||||||||
Sponsor Name:Melinta Therapeutics, Inc | |||||||||||||
Full Title: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE BLIND, ACTIVE CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DELAFLOXACIN COMPARED WITH VANCOMYCIN + AZTREONAM IN PATIENTS WITH ACUTE BACTERIAL S... | |||||||||||||
Medical condition: ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) LV (Completed) ES (Completed) BG (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003884-20 | Sponsor Protocol Number: MK-1986-018 | Start Date*: 2017-06-05 | |||||||||||
Sponsor Name:Merck Sharp & Dohme LLC | |||||||||||||
Full Title: A Phase III Randomized, Active-comparator-Controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator, in Subjects 3 Months to <12 Years of Age with A... | |||||||||||||
Medical condition: Acute Bacterial Skin and Skin Structure Infections (ABSSSI) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA DE (Completed) PL (Completed) BG (Completed) LT (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002669-45 | Sponsor Protocol Number: ICL-23-ABSSSI1 | Start Date*: 2016-02-18 | |||||||||||
Sponsor Name:Motif BioSciences Inc. | |||||||||||||
Full Title: A Phase 3, randomized, double-blind, multicenter study to evaluate the safety and efficacy of intravenous iclaprim versus vancomycin in the treatment of acute bacterial skin and skin structure infe... | |||||||||||||
Medical condition: Acute bacterial skin and skin structure infections (ABSSSIs) suspected or confirmed to be due to Gram-positive pathogens. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) DE (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001125-15 | Sponsor Protocol Number: ATB-202 | Start Date*: 2018-07-16 | |||||||||||||||||||||
Sponsor Name:Atox Bio | |||||||||||||||||||||||
Full Title: Phase III, randomized, double-blind, placebo controlled, parallel-group, study of AB103 as compared to placebo in patients with necrotizing soft tissue infections (NSTI) | |||||||||||||||||||||||
Medical condition: Necrosis of soft tissue infections (NSTI) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-002687-16 | Sponsor Protocol Number: ICL-24-ABSSSI2 | Start Date*: 2016-05-05 | |||||||||||
Sponsor Name:Motif BioSciences Inc. | |||||||||||||
Full Title: A Phase 3, randomized, double-blind, multicenter study to evaluate the safety and efficacy of intravenous iclaprim versus vancomycin in the treatment of acute bacterial skin and skin structure infe... | |||||||||||||
Medical condition: Acute bacterial skin and skin structure infections (ABSSSIs) suspected or confirmed to be due to Gram-positive pathogens. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) BE (Completed) HU (Completed) PT (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004983-39 | Sponsor Protocol Number: RX-3341-303 | Start Date*: 2015-01-26 | |||||||||||
Sponsor Name:Melinta Therapeutics, Inc | |||||||||||||
Full Title: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF IV AND ORAL DELAFLOXACIN COMPARED WITH VANCOMYCIN + AZTREONAM IN PATIENTS WITH ACUTE... | |||||||||||||
Medical condition: ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) EE (Completed) LV (Completed) SK (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021424-94 | Sponsor Protocol Number: TMC-ORI-10-01 | Start Date*: 2012-03-16 | |||||||||||||||||||||||||||||||
Sponsor Name:The Medicines Company | |||||||||||||||||||||||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Single-Dose IV Oritavancin versus IV Vancomycin for the Treatment of Patients with Acute Bacterial Skin and Skin... | |||||||||||||||||||||||||||||||||
Medical condition: Treatment of Patients with acute bacterial skin and skin structure infections | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) DE (Completed) PL (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
